Skip to content

Resmed

NYSE: RMD · USD

Resmed financials

6 charts

Revenue

USD millions

$1,463.647M
Resmed Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2011 Q1$282.012M; Change unavailable vs FY 2010 Q4
FY 2011 Q2$305.986M; +8.5% vs FY 2011 Q1
FY 2011 Q3$313.258M; +2.4% vs FY 2011 Q2
FY 2011 Q4$341.893M; +9.1% vs FY 2011 Q3
FY 2012 Q1$314.774M; −7.9% vs FY 2011 Q4
FY 2012 Q2$332.738M; +5.7% vs FY 2012 Q1
FY 2012 Q3$349.073M; +4.9% vs FY 2012 Q2
FY 2012 Q4$371.929M; +6.5% vs FY 2012 Q3
FY 2013 Q1$339.731M; −8.7% vs FY 2012 Q4
FY 2013 Q2$376.537M; +10.8% vs FY 2013 Q1
FY 2013 Q3$383.581M; +1.9% vs FY 2013 Q2
FY 2013 Q4$414.607M; +8.1% vs FY 2013 Q3
FY 2014 Q1$357.662M; −13.7% vs FY 2013 Q4
FY 2014 Q2$384.341M; +7.5% vs FY 2014 Q1
FY 2014 Q3$397.758M; +3.5% vs FY 2014 Q2
FY 2014 Q4$415.211M; +4.4% vs FY 2014 Q3
FY 2015 Q1$380.399M; −8.4% vs FY 2014 Q4
FY 2015 Q2$422.952M; +11.2% vs FY 2015 Q1
FY 2015 Q3$422.497M; −0.1% vs FY 2015 Q2
FY 2015 Q4$453.064M; +7.2% vs FY 2015 Q3
FY 2016 Q1$411.647M; −9.1% vs FY 2015 Q4
FY 2016 Q2$454.54M; +10.4% vs FY 2016 Q1
FY 2016 Q3$453.879M; −0.1% vs FY 2016 Q2
FY 2016 Q4$518.647M; +14.3% vs FY 2016 Q3
FY 2017 Q1Unavailable; Change unavailable vs FY 2016 Q4
FY 2017 Q2Unavailable; Change unavailable vs FY 2017 Q1
FY 2017 Q3Unavailable; Change unavailable vs FY 2017 Q2
FY 2017 Q4Unavailable; Change unavailable vs FY 2017 Q3
FY 2018 Q1$523.659M; Change unavailable vs FY 2017 Q4
FY 2018 Q2$601.273M; +14.8% vs FY 2018 Q1
FY 2018 Q3$591.634M; −1.6% vs FY 2018 Q2
FY 2018 Q4$623.63M; +5.4% vs FY 2018 Q3
FY 2019 Q1$588.279M; −5.7% vs FY 2018 Q4
FY 2019 Q2$651.1M; +10.7% vs FY 2019 Q1
FY 2019 Q3$662.228M; +1.7% vs FY 2019 Q2
FY 2019 Q4Unavailable; Change unavailable vs FY 2019 Q3
FY 2020 Q1$681.056M; Change unavailable vs FY 2019 Q4
FY 2020 Q2$736.157M; +8.1% vs FY 2020 Q1
FY 2020 Q3$769.455M; +4.5% vs FY 2020 Q2
FY 2020 Q4Unavailable; Change unavailable vs FY 2020 Q3
FY 2021 Q1$751.944M; Change unavailable vs FY 2020 Q4
FY 2021 Q2$800.011M; +6.4% vs FY 2021 Q1
FY 2021 Q3$768.767M; −3.9% vs FY 2021 Q2
FY 2021 Q4$876.103M; +14.0% vs FY 2021 Q3
FY 2022 Q1$904.015M; +3.2% vs FY 2021 Q4
FY 2022 Q2$894.874M; −1.0% vs FY 2022 Q1
FY 2022 Q3$864.5M; −3.4% vs FY 2022 Q2
FY 2022 Q4$914.737M; +5.8% vs FY 2022 Q3
FY 2023 Q1$950.294M; +3.9% vs FY 2022 Q4
FY 2023 Q2$1,033.744M; +8.8% vs FY 2023 Q1
FY 2023 Q3$1,116.898M; +8.0% vs FY 2023 Q2
FY 2023 Q4$1,122.057M; +0.5% vs FY 2023 Q3
FY 2024 Q1$1,102.321M; −1.8% vs FY 2023 Q4
FY 2024 Q2$1,162.801M; +5.5% vs FY 2024 Q1
FY 2024 Q3$1,196.98M; +2.9% vs FY 2024 Q2
FY 2024 Q4$1,223.195M; +2.2% vs FY 2024 Q3
FY 2025 Q1$1,224.509M; +0.1% vs FY 2024 Q4
FY 2025 Q2$1,282.089M; +4.7% vs FY 2025 Q1
FY 2025 Q3$1,291.736M; +0.8% vs FY 2025 Q2
FY 2025 Q4$1,347.993M; +4.4% vs FY 2025 Q3
FY 2026 Q1$1,335.582M; −0.9% vs FY 2025 Q4
FY 2026 Q2$1,422.808M; +6.5% vs FY 2026 Q1
FY 2026 Q3$1,431.406M; +0.6% vs FY 2026 Q2
FY 2026 Q4$1,463.647M; +2.3% vs FY 2026 Q3
Sep 30, 2010 through Sep 25, 2026

Free cash flow

USD millions

$403.504M
Resmed Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2011 Q1$43.81M; Change unavailable vs FY 2010 Q4
FY 2011 Q2$50.525M; +15.3% vs FY 2011 Q1
FY 2011 Q3$65.364M; +29.4% vs FY 2011 Q2
FY 2011 Q4$56.882M; −13.0% vs FY 2011 Q3
FY 2012 Q1$76.645M; +34.7% vs FY 2011 Q4
FY 2012 Q2$98.322M; +28.3% vs FY 2012 Q1
FY 2012 Q3$76.148M; −22.6% vs FY 2012 Q2
FY 2012 Q4$84.909M; +11.5% vs FY 2012 Q3
FY 2013 Q1$64.423M; −24.1% vs FY 2012 Q4
FY 2013 Q2$79.843M; +23.9% vs FY 2013 Q1
FY 2013 Q3$87.059M; +9.0% vs FY 2013 Q2
FY 2013 Q4$107.919M; +24.0% vs FY 2013 Q3
FY 2014 Q1$73.673M; −31.7% vs FY 2013 Q4
FY 2014 Q2$64.491M; −12.5% vs FY 2014 Q1
FY 2014 Q3$83.311M; +29.2% vs FY 2014 Q2
FY 2014 Q4$97.071M; +16.5% vs FY 2014 Q3
FY 2015 Q1$65.855M; −32.2% vs FY 2014 Q4
FY 2015 Q2$87.008M; +32.1% vs FY 2015 Q1
FY 2015 Q3$80.35M; −7.7% vs FY 2015 Q2
FY 2015 Q4$87.465M; +8.9% vs FY 2015 Q3
FY 2016 Q1$105.669M; +20.8% vs FY 2015 Q4
FY 2016 Q2$132.909M; +25.8% vs FY 2016 Q1
FY 2016 Q3$108.95M; −18.0% vs FY 2016 Q2
FY 2016 Q4$141.871M; +30.2% vs FY 2016 Q3
FY 2017 Q1$71.683M; −49.5% vs FY 2016 Q4
FY 2017 Q2$105.212M; +46.8% vs FY 2017 Q1
FY 2017 Q3$52.988M; −49.6% vs FY 2017 Q2
FY 2017 Q4$121.951M; +130.1% vs FY 2017 Q3
FY 2018 Q1$77.953M; −36.1% vs FY 2017 Q4
FY 2018 Q2Unavailable; Change unavailable vs FY 2018 Q1
FY 2018 Q3$136.115M; Change unavailable vs FY 2018 Q2
FY 2018 Q4$111.796M; −17.9% vs FY 2018 Q3
FY 2019 Q1$35.125M; −68.6% vs FY 2018 Q4
FY 2019 Q2$111.037M; +216.1% vs FY 2019 Q1
FY 2019 Q3$124.564M; +12.2% vs FY 2019 Q2
FY 2019 Q4$119.615M; −4.0% vs FY 2019 Q3
FY 2020 Q1$139.692M; +16.8% vs FY 2019 Q4
FY 2020 Q2$44.832M; −67.9% vs FY 2020 Q1
FY 2020 Q3$210.106M; +368.7% vs FY 2020 Q2
FY 2020 Q4$312.295M; +48.6% vs FY 2020 Q3
FY 2021 Q1$130.498M; −58.2% vs FY 2020 Q4
FY 2021 Q2$134.974M; +3.4% vs FY 2021 Q1
FY 2021 Q3$169.916M; +25.9% vs FY 2021 Q2
FY 2021 Q4$198.618M; +16.9% vs FY 2021 Q3
FY 2022 Q1$-92.997M; −146.8% vs FY 2021 Q4
FY 2022 Q2$189.472M; +303.7% vs FY 2022 Q1
FY 2022 Q3$68.994M; −63.6% vs FY 2022 Q2
FY 2022 Q4$50.843M; −26.3% vs FY 2022 Q3
FY 2023 Q1$15.606M; −69.3% vs FY 2022 Q4
FY 2023 Q2$101.286M; +549.0% vs FY 2023 Q1
FY 2023 Q3$253.748M; +150.5% vs FY 2023 Q2
FY 2023 Q4$202.987M; −20.0% vs FY 2023 Q3
FY 2024 Q1$256.248M; +26.2% vs FY 2023 Q4
FY 2024 Q2$249.479M; −2.6% vs FY 2024 Q1
FY 2024 Q3$380.84M; +52.7% vs FY 2024 Q2
FY 2024 Q4$415.233M; +9.0% vs FY 2024 Q3
FY 2025 Q1$307.698M; −25.9% vs FY 2024 Q4
FY 2025 Q2$287.979M; −6.4% vs FY 2025 Q1
FY 2025 Q3$557.865M; +93.7% vs FY 2025 Q2
FY 2025 Q4$508.181M; −8.9% vs FY 2025 Q3
FY 2026 Q1$414.356M; −18.5% vs FY 2025 Q4
FY 2026 Q2$311.206M; −24.9% vs FY 2026 Q1
FY 2026 Q3$520.478M; +67.2% vs FY 2026 Q2
FY 2026 Q4$403.504M; −22.5% vs FY 2026 Q3

Net margin

%

26.2%
Resmed Net margin. Reported fiscal history.
Fiscal period%
FY 2011 Q120.11%
FY 2011 Q219.1%
FY 2011 Q317.03%
FY 2011 Q417.1%
FY 2012 Q116.05%
FY 2012 Q218.9%
FY 2012 Q318.51%
FY 2012 Q420.66%
FY 2013 Q120.98%
FY 2013 Q220.7%
FY 2013 Q322.14%
FY 2013 Q417.61%
FY 2014 Q122.63%
FY 2014 Q222.54%
FY 2014 Q322.62%
FY 2014 Q421.13%
FY 2015 Q121.89%
FY 2015 Q221.56%
FY 2015 Q321.53%
FY 2015 Q419.3%
FY 2016 Q119.53%
FY 2016 Q219.91%
FY 2016 Q319.49%
FY 2016 Q417.94%
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q4—
FY 2018 Q116.45%
FY 2018 Q21.58%
FY 2018 Q318.61%
FY 2018 Q417.61%
FY 2019 Q117.97%
FY 2019 Q219.14%
FY 2019 Q315.92%
FY 2019 Q4—
FY 2020 Q117.64%
FY 2020 Q221.81%
FY 2020 Q321.2%
FY 2020 Q4—
FY 2021 Q123.72%
FY 2021 Q222.44%
FY 2021 Q3-10.21%
FY 2021 Q422.27%
FY 2022 Q122.52%
FY 2022 Q222.55%
FY 2022 Q320.71%
FY 2022 Q421.32%
FY 2023 Q122.15%
FY 2023 Q221.76%
FY 2023 Q320.82%
FY 2023 Q420.47%
FY 2024 Q119.91%
FY 2024 Q217.96%
FY 2024 Q325.1%
FY 2024 Q423.89%
FY 2025 Q125.43%
FY 2025 Q226.88%
FY 2025 Q328.26%
FY 2025 Q428.17%
FY 2026 Q126.1%
FY 2026 Q227.59%
FY 2026 Q327.86%
FY 2026 Q426.2%

P/E

× · TTM · Daily

21.15×
Resmed P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2011-11-3018.18×2011-09-30
2011-12-3017.72×2011-09-30
2012-01-3120.25×2011-09-30
2012-02-2919.45×2011-12-31
2012-03-3020.52×2011-12-31
2012-04-3022.58×2011-12-31
2012-05-3119.28×2012-03-31
2012-06-2919.42×2012-03-31
2012-07-3119.64×2012-03-31
2012-08-3123.38×2012-03-31
2012-09-2825.18×2012-03-31
2012-10-3124.85×2012-03-31
2012-11-3021.78×2012-09-30
2012-12-3122.03×2012-09-30
2013-01-3123.21×2012-09-30
2013-02-2822.45×2012-12-31
2013-03-2823.4×2012-12-31
2013-04-3024.23×2012-12-31
2013-05-3122.64×2013-03-31
2013-06-2821.28×2013-03-31
2013-07-3122.47×2013-03-31
2013-08-3022.28×2013-03-31
2013-09-3024.91×2013-03-31
2013-10-3123.76×2013-09-30
2013-11-2922.41×2013-09-30
2013-12-3121.62×2013-09-30
2014-01-3119.47×2013-12-31
2014-02-2819.66×2013-12-31
2014-03-3119.95×2013-12-31
2014-04-3022.26×2013-12-31
2014-05-3021.71×2014-03-31
2014-06-3021.96×2014-03-31
2014-07-3122.44×2014-03-31
2014-08-2922×2014-06-30
2014-09-3020.43×2014-06-30
2014-10-3121.65×2014-06-30
2014-11-2822.06×2014-06-30
2014-12-3123.24×2014-06-30
2015-01-3025.9×2014-06-30
2015-02-2726.69×2014-06-30
2015-03-3129.76×2014-06-30
2015-04-3025.86×2015-03-31
2015-05-2923.79×2015-03-31
2015-06-3022.8×2015-03-31
2015-07-3123.43×2015-03-31
2015-08-3121.03×2015-06-30
2015-09-3020.64×2015-06-30
2015-10-3023.36×2015-09-30
2015-11-3024.16×2015-09-30
2015-12-3121.77×2015-09-30
2016-01-2922.91×2015-12-31
2016-02-2922.99×2015-12-31
2016-03-3123.36×2015-12-31
2016-04-2922.54×2015-12-31
2016-05-3124.02×2016-03-31
2016-06-3025.71×2016-03-31
2016-07-2928.01×2016-03-31
2016-08-3126.96×2016-06-30
2016-09-3026.2×2016-06-30
2016-10-3124.4×2016-09-30
2016-11-3025.09×2016-09-30
2016-12-3025.33×2016-09-30
2017-01-3128.71×2016-12-31
2017-02-2830.61×2016-12-31
2017-03-3130.59×2016-12-31
2017-04-2828.9×2016-12-31
2017-05-3130.41×2017-03-31
2017-06-3033.3×2017-03-31
2017-07-3132.98×2017-03-31
2017-08-3132.35×2017-06-30
2017-09-2932.09×2017-06-30
2017-10-3135.1×2017-06-30
2017-11-3035.61×2017-06-30
2017-12-2935.31×2017-06-30
2018-01-3142.03×2017-06-30
2018-02-2839.73×2017-06-30
2018-03-2941.06×2017-06-30
2018-04-3039.46×2017-06-30
2018-05-3142.87×2017-06-30
2018-06-2943.19×2017-06-30
2018-07-3144.11×2017-06-30
2018-08-3146.46×2017-06-30
2018-09-2848.09×2017-06-30
2018-10-3143.14×2017-09-30
2018-11-3045.53×2017-09-30
2018-12-3146.38×2017-09-30
2019-01-3138.76×2017-09-30
2019-02-2851.69×2017-12-31
2019-03-2952.46×2017-12-31
2019-04-3052.74×2017-12-31
2019-05-3153.46×2018-03-31
2019-06-2857.16×2018-03-31
2019-07-3160.28×2018-03-31
2019-08-3065.25×2018-03-31
2019-09-3063.29×2018-03-31
2019-10-3169.29×2018-03-31
2019-11-2970.07×2018-03-31
2019-12-3172.59×2018-03-31
2020-01-3174.46×2018-03-31
2020-02-2874.46×2018-03-31
2020-03-3168.99×2018-03-31
2020-04-3072.75×2018-03-31
2020-05-2975.33×2018-03-31
2020-06-3089.94×2018-03-31
2020-07-3194.86×2018-03-31
2020-08-3142.5×2020-06-30
2020-09-3040.3×2020-06-30
2020-10-3045.12×2020-06-30
2020-11-3049.27×2020-06-30
2020-12-3149.97×2020-06-30
2021-01-2947.38×2020-06-30
2021-02-2645.32×2020-06-30
2021-03-3145.61×2020-06-30
2021-04-3044.19×2020-06-30
2021-05-2865.51×2021-03-31
2021-06-3078.45×2021-03-31
2021-07-3086.5×2021-03-31
2021-08-3189.77×2021-06-30
2021-09-3081.44×2021-06-30
2021-10-2981.24×2021-06-30
2021-11-3074.89×2021-09-30
2021-12-3176.55×2021-09-30
2022-01-3164.4×2021-12-31
2022-02-2869.51×2021-12-31
2022-03-3168.31×2021-12-31
2022-04-2956.33×2021-12-31
2022-05-3138.36×2022-03-31
2022-06-3039.52×2022-03-31
2022-07-2945.35×2022-03-31
2022-08-3141.5×2022-06-30
2022-09-3041.19×2022-06-30
2022-10-3141.86×2022-09-30
2022-11-3043.08×2022-09-30
2022-12-3038.95×2022-09-30
2023-01-3141.59×2022-12-31
2023-02-2838.79×2022-12-31
2023-03-3139.88×2022-12-31
2023-04-2843.88×2022-12-31
2023-05-3136×2023-03-31
2023-06-3037.32×2023-03-31
2023-07-3137.98×2023-03-31
2023-08-3126.25×2023-06-30
2023-09-2924.32×2023-06-30
2023-10-3122.98×2023-09-30
2023-11-3025.66×2023-09-30
2023-12-2927.99×2023-09-30
2024-01-3131.52×2023-12-31
2024-02-2928.79×2023-12-31
2024-03-2832.82×2023-12-31
2024-04-3032.92×2024-03-31
2024-05-3131.74×2024-03-31
2024-06-2829.45×2024-03-31
2024-07-3132.81×2024-03-31
2024-08-3035.41×2024-06-30
2024-09-3035.28×2024-06-30
2024-10-3132.16×2024-09-30
2024-11-2933.03×2024-09-30
2024-12-3130.33×2024-09-30
2025-01-3131.32×2024-09-30
2025-02-2827.58×2024-12-31
2025-03-3126.44×2024-12-31
2025-04-3026.52×2025-03-31
2025-05-3027.44×2025-03-31
2025-06-3028.92×2025-03-31
2025-07-3130.49×2025-03-31
2025-08-2928.82×2025-06-30
2025-09-3028.74×2025-06-30
2025-10-3125.92×2025-06-30
2025-11-2826.14×2025-09-30
2025-12-3124.61×2025-09-30
2026-01-3026.39×2025-09-30
2026-02-2725.24×2025-12-31
2026-03-3122.11×2025-12-31
2026-04-3021.06×2025-12-31
2026-05-2918.28×2026-03-31
2026-06-3018.69×2026-03-31
2026-07-3120.23×2026-03-31
2026-08-3122.87×2026-06-30
2026-09-2521.15×2026-06-30
Mean 36.49×Median 29.96×29% below median

ROIC

% · Annual / TTM

26.73%
Resmed ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q4—
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q319.3%
FY 2012 Q421.08%
FY 2013 Q122.62%
FY 2013 Q224.54%
FY 2013 Q326.01%
FY 2013 Q427.15%
FY 2014 Q127.59%
FY 2014 Q227.95%
FY 2014 Q328.06%
FY 2014 Q429.65%
FY 2015 Q129.22%
FY 2015 Q229.03%
FY 2015 Q328.86%
FY 2015 Q428.51%
FY 2016 Q129.14%
FY 2016 Q227.47%
FY 2016 Q326.46%
FY 2016 Q420.79%
FY 2017 Q120.69%
FY 2017 Q219.84%
FY 2017 Q318.72%
FY 2017 Q415.98%
FY 2018 Q1—
FY 2018 Q213.73%
FY 2018 Q314.64%
FY 2018 Q415.02%
FY 2019 Q1—
FY 2019 Q218.26%
FY 2019 Q317.76%
FY 2019 Q416.89%
FY 2020 Q117.85%
FY 2020 Q216.44%
FY 2020 Q318.12%
FY 2020 Q421.44%
FY 2021 Q122.49%
FY 2021 Q221.81%
FY 2021 Q314.56%
FY 2021 Q415.03%
FY 2022 Q114.9%
FY 2022 Q215.12%
FY 2022 Q322.95%
FY 2022 Q422.84%
FY 2023 Q121.85%
FY 2023 Q218.99%
FY 2023 Q319.95%
FY 2023 Q420.04%
FY 2024 Q119.81%
FY 2024 Q217.15%
FY 2024 Q318.39%
FY 2024 Q419.96%
FY 2025 Q121.14%
FY 2025 Q223.29%
FY 2025 Q325.12%
FY 2025 Q426.16%
FY 2026 Q126.56%
FY 2026 Q227.09%
FY 2026 Q328.03%
FY 2026 Q426.73%

Capital allocation

% of tracked cash uses

$668.536M
Resmed capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q117.2% · $15.333M23.73% · $21.15M25.4% · $22.637MUnavailable33.66% · $30M100% · $89.12M
FY 2011 Q226.99% · $17.786M0% · $0M28.42% · $18.724MUnavailable44.59% · $29.382M100% · $65.892M
FY 2011 Q311.38% · $16.044M0.92% · $1.3M42.22% · $59.534MUnavailable45.48% · $64.137M100% · $141.015M
FY 2011 Q421.82% · $17.446M0% · $0M78.09% · $62.447MUnavailable0.09% · $0.072M100% · $79.965M
FY 2012 Q15.39% · $12.878M21.73% · $51.923M50.93% · $121.697MUnavailable21.95% · $52.456M100% · $238.954M
FY 2012 Q29.5% · $12.311M0% · $0M88.23% · $114.274MUnavailable2.27% · $2.937M100% · $129.522M
FY 2012 Q312.86% · $9.878M1.82% · $1.399M84.68% · $65.057MUnavailable0.64% · $0.494M100% · $76.828M
FY 2012 Q46.94% · $12.068M0% · $0M52.75% · $91.715MUnavailable40.31% · $70.098M100% · $173.881M
FY 2013 Q127.47% · $13.831M10.76% · $5.418M16.08% · $8.095M45.37% · $22.843M0.31% · $0.158M100% · $50.345M
FY 2013 Q217.34% · $13.804M0% · $0M50.19% · $39.956M32.46% · $25.845M0.01% · $0.009M100% · $79.614M
FY 2013 Q317.89% · $19.941M0% · $0M60.35% · $67.288M21.75% · $24.251M0.01% · $0.009M100% · $111.489M
FY 2013 Q47.58% · $16.003M0% · $0M33.57% · $70.919M11.49% · $24.265M47.36% · $100.045M100% · $211.232M
FY 2014 Q122.32% · $16.752MUnavailable30.4% · $22.822M47.27% · $35.478M0.01% · $0.009M100% · $75.061M
FY 2014 Q24.05% · $19.674MUnavailable14.56% · $70.77M7.33% · $35.647M74.06% · $360.01M100% · $486.101M
FY 2014 Q39.67% · $17.784M0% · $0M41.23% · $75.806M19.18% · $35.262M29.92% · $55.01M100% · $183.862M
FY 2014 Q47.98% · $18.512M0.29% · $0.68M14.12% · $32.771M15.14% · $35.131M62.48% · $145.006M100% · $232.1M
FY 2015 Q118.14% · $20.681M6.42% · $7.318M41.05% · $46.803M34.38% · $39.199M0.01% · $0.01M100% · $114.011M
FY 2015 Q217.92% · $18.994M9.87% · $10.463M35.14% · $37.252M37.06% · $39.278M0.01% · $0.009M100% · $105.996M
FY 2015 Q313.26% · $10.591M11.48% · $9.175M24.08% · $19.24M49.29% · $39.385M1.89% · $1.508M100% · $79.899M
FY 2015 Q44.2% · $12.236M0.84% · $2.451M19.58% · $57.005M13.53% · $39.4M61.84% · $180.009M100% · $291.101M
FY 2016 Q114.1% · $16.403MUnavailable49.73% · $57.857M36.17% · $42.079M0.01% · $0.008M100% · $116.347M
FY 2016 Q27.23% · $14.531MUnavailable22.01% · $44.201M20.9% · $41.975M49.86% · $100.152M100% · $200.859M
FY 2016 Q35.53% · $13.199M37.94% · $90.527M0% · $0M17.59% · $41.972M38.94% · $92.932M100% · $238.63M
FY 2016 Q41.52% · $14.401M84.45% · $799.219M0% · $0M4.45% · $42.104M9.57% · $90.602M100% · $946.326M
FY 2017 Q116.35% · $14.56M3.47% · $3.09MUnavailable52.09% · $46.378M28.08% · $25M100% · $89.028M
FY 2017 Q212.63% · $14.687M0.08% · $0.094MUnavailable39.98% · $46.487M47.3% · $55M100% · $116.268M
FY 2017 Q34.34% · $14.61M0.06% · $0.21MUnavailable13.87% · $46.681M81.72% · $275M100% · $336.501M
FY 2017 Q47.09% · $18.362M1.5% · $3.88MUnavailable18.07% · $46.8M73.35% · $190M100% · $259.042M
FY 2018 Q19.12% · $16.03MUnavailableUnavailable28.28% · $49.698M62.6% · $110M100% · $175.728M
FY 2018 Q224.26% · $15.97MUnavailableUnavailable75.74% · $49.855M0% · $0M100% · $65.825M
FY 2018 Q33.58% · $12.961MUnavailable5.34% · $19.356M13.79% · $49.974M77.29% · $280M100% · $362.291M
FY 2018 Q42.07% · $17.62M0.05% · $0.42M3.05% · $25.904M5.88% · $49.97M88.95% · $756.242M100% · $850.156M
FY 2019 Q14.36% · $12.994M42.46% · $126.439M6.52% · $19.399M17.73% · $52.793M28.93% · $86.133M100% · $297.758M
FY 2019 Q21.93% · $18.431M64.23% · $612.81M0.36% · $3.445M5.53% · $52.774M27.95% · $266.665M100% · $954.125M
FY 2019 Q33.22% · $15.082M45.27% · $212.316M0% · $0M11.31% · $53.025M40.21% · $188.596M100% · $469.019M
FY 2019 Q49.04% · $22.203MUnavailable0% · $0M21.62% · $53.12M69.34% · $170.351M100% · $245.674M
FY 2020 Q13.27% · $22.671MUnavailableUnavailable8.09% · $56.052M88.64% · $614.003M100% · $692.726M
FY 2020 Q215.01% · $25.1MUnavailableUnavailable33.57% · $56.15M51.42% · $86.009M100% · $167.259M
FY 2020 Q310.08% · $29.589M8.34% · $24.487MUnavailable19.22% · $56.408M62.35% · $183M100% · $293.484M
FY 2020 Q43.78% · $17.97M0% · $0MUnavailable11.88% · $56.483M84.34% · $401M100% · $475.453M
FY 2021 Q15.51% · $13.501MUnavailableUnavailable23.06% · $56.511M71.43% · $175M100% · $245.012M
FY 2021 Q210.83% · $34.942MUnavailableUnavailable17.56% · $56.654M71.61% · $231M100% · $322.596M
FY 2021 Q310.83% · $26.362M12.44% · $30.267MUnavailable23.32% · $56.752M53.41% · $130M100% · $243.381M
FY 2021 Q416.51% · $27.907M4.95% · $8.363MUnavailable33.59% · $56.796M44.95% · $76M100% · $169.066M
FY 2022 Q130.88% · $27.34M0% · $0MUnavailable69.12% · $61.189M0% · $0M100% · $88.529M
FY 2022 Q211.54% · $30.407M13.63% · $35.915MUnavailable23.24% · $61.245M51.6% · $136M100% · $263.567M
FY 2022 Q344.1% · $48.445M0% · $0MUnavailable55.9% · $61.419M0% · $0M100% · $109.864M
FY 2022 Q422.55% · $28.643M5.41% · $6.869MUnavailable48.42% · $61.488M23.62% · $30M100% · $127M
FY 2023 Q120.38% · $29.056M13.4% · $19.1MUnavailable45.19% · $64.431M21.04% · $30M100% · $142.587M
FY 2023 Q22.49% · $27.35M90.28% · $992.125MUnavailable5.87% · $64.5M1.36% · $15M100% · $1,098.975M
FY 2023 Q39.34% · $28.817M0% · $0M0% · $0M20.96% · $64.64M69.7% · $215M100% · $308.457M
FY 2023 Q414.02% · $34.449M0.62% · $1.524M0% · $0M26.34% · $64.705M59.02% · $145M100% · $245.678M
FY 2024 Q17.72% · $30.035M26.54% · $103.183M0% · $0M18.16% · $70.597M47.58% · $185M100% · $388.815M
FY 2024 Q28.29% · $23.353M2.67% · $7.505M17.76% · $50.007M25.1% · $70.678M46.17% · $130M100% · $281.543M
FY 2024 Q35.81% · $21.191M0.84% · $3.079M13.71% · $50M19.33% · $70.492M60.31% · $220M100% · $364.762M
FY 2024 Q45.35% · $24.881M4.23% · $19.697M10.75% · $50.004M15.17% · $70.553M64.5% · $300M100% · $465.135M
FY 2025 Q110.15% · $17.84M0% · $0M28.45% · $50.005M44.32% · $77.891M17.07% · $30M100% · $175.736M
FY 2025 Q211.53% · $20.644M0.37% · $0.67M41.89% · $74.986M43.41% · $77.695M2.79% · $5M100% · $178.995M
FY 2025 Q311.98% · $20.796M0% · $0M43.24% · $75.026M44.78% · $77.704M0% · $0M100% · $173.526M
FY 2025 Q48.69% · $30.585M39.4% · $138.578M28.43% · $100.008M22.06% · $77.59M1.42% · $5M100% · $351.761M
FY 2026 Q115.28% · $42.965M0.19% · $0.522M53.34% · $150.01M31.2% · $87.75M0% · $0M100% · $281.247M
FY 2026 Q29.64% · $28.539M0% · $0M59.1% · $175.014M29.58% · $87.584M1.69% · $5M100% · $296.137M
FY 2026 Q310.49% · $33.654M7.76% · $24.883M54.56% · $175.013M27.19% · $87.238M0% · $0M100% · $320.788M
FY 2026 Q47.65% · $51.127M48.66% · $325.319M29.92% · $200M13.03% · $87.09M0.75% · $5M100% · $668.536M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Resmed.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources